CLINICAL_TRIALS
trial_result
· 2026-04-03
Clinical Trial Update: Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy [Phase 2]
Summary
Phase 2b trial update for RPT904 as monotherapy in participants with IgE-mediated food allergy; study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RAPT Therapeutics, Inc. | Conditions: Ig-E Mediated Food Allergy | Phase 2 | Status: RECRUITING